Skip to main content
. 2016 Oct 28;22(40):8883–8891. doi: 10.3748/wjg.v22.i40.8883

Table 1.

The proposed management decisions and oncologic surveillance program regarding gastric hyperplastic polyps

Before endoscopic resection of GHPs
GHP without dysplasia or cancer, asymptomatic and small (< 5 mm) - surveillance not recommended
GHP symptomatic or larger than 5 mm - endoscopic resection recommended
GHP with dysplasia or cancer - endoscopic or surgical resection recommended
GHP not classified for removal due to the risk of postsurgical complications - periodic gastroscopies with representative biopsies every 1-2 yr
GHP in patients with high risk of gastric cancer1 - gastroscopies every 1-2 yr
GHP with dysplasia outside the polyp - consider subtotal gastrectomy and gastroscopies every 1-3 yr
After endoscopic resection of GHPs
After complete resection of GHP with dysplasia - gastroscopy 1 yr later, and then depending on the clinical situation
After complete resection of GHP with early gastric cancer - gastroscopy 1 yr after and then 3 yr after
After incomplete resection of GHP with gastric cancer - consider gastrectomy with lymphadenectomy
1

Family history of gastric cancer or OLGA 3-4 on histopathological examination. GHP: Gastric hyperplastic polyp.